Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$484K Buy
+1,813
New +$502K 0.04% 336
2020
Q3
Sell
-2,019
Closed -$379K 327
2020
Q2
$379K Buy
2,019
+203
+11% +$38.5K 0.08% 214
2020
Q1
$322K Buy
1,816
+318
+21% +$61.7K 0.08% 208
2019
Q4
$306K Sell
1,498
-389
-21% -$71.3K 0.06% 253
2019
Q3
$286K Buy
1,887
+46
+2% +$7.49K 0.06% 252
2019
Q2
$290K Buy
1,841
+41
+2% +$6.42K 0.07% 265
2019
Q1
$289K Buy
1,800
+51
+3% +$9.31K 0.07% 250
2018
Q4
$332K Buy
+1,749
New +$365K 0.09% 213
2018
Q1
Sell
-1,422
Closed -$289K 328
2017
Q4
$289K Sell
1,422
-183
-11% -$36.4K 0.08% 227
2017
Q3
$300K Buy
1,605
+68
+4% +$12.1K 0.09% 223
2017
Q2
$257K Buy
1,537
+161
+12% +$25.9K 0.09% 205
2017
Q1
$202K Buy
+1,376
New +$203K 0.07% 225

Other funds holding CI

Smith, Moore & Co's CI Position: Q1 2026 in Review

Smith, Moore & Co opened a new position in Cigna (CI) in Q1 2026: 1,813 shares worth $484K. The stake represents 0.04% of the portfolio and ranks #336 among its holdings. This is a return to the name: Smith, Moore & Co previously reported a position in CI as recently as Q2 2020.

Smith, Moore & Co first reported a position in CI in Q1 2017 and has held it in 12 quarters since. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Smith, Moore & Co held 1,813 shares of Cigna worth $484K as of Q1 2026.
  • Cigna was a new Smith, Moore & Co position in Q1 2026.
  • Cigna made up 0.04% of Smith, Moore & Co's portfolio in Q1 2026, its #336 holding.
  • Smith, Moore & Co first reported a position in Cigna in Q1 2017 and has held it in 12 quarters since.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.